StockData
Abpro Holdings, Inc. logo

Abpro Holdings, Inc. (ABPO) stock

ABPOOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as ABPWW
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 0/30
$0.41+0.00 (+0.11%)

Close on Oct 19, 2026Market cap $2.41MP/E –Yield –

Abpro net income

Net income is the profit left for shareholders after every expense, interest and tax.

Abpro's net income for the twelve months ending Jun 30, 2024 was -$78.72K, down 101.6% year over year. For fiscal 2023 it was $2.82M, up 218.1% from the year before.

Annual net income

PeriodPeriod endValueChange
FY2023Dec 31, 2023$2.82M+218.1%
FY2022Dec 31, 2022$886.92K–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q1 FY2025Mar 31, 2025-$3.89M–
Q2 FY2024Jun 30, 2024-$338.85K-142.2%
Q1 FY2024Mar 31, 2024$312.00K-84.9%
Q4 FY2023Dec 31, 2023-$7.24K-100.5%
Q3 FY2023Sep 30, 2023-$44.63K-106.8%
Q2 FY2023Jun 30, 2023$802.80K–
Q1 FY2023Mar 31, 2023$2.07M–
Q4 FY2022Dec 31, 2022$1.46M–
Q3 FY2022Sep 30, 2022$652.42K–
Q2 FY2022Jun 30, 2022-$196.92K–
Q1 FY2022Mar 31, 2022-$1.03M–
Q3 FY2021Sep 30, 2021-$1.00K–

More Abpro figures

See a number that looks wrong?